Riverview Trust CO Abb Vie Inc. Transaction History

Riverview Trust CO

$108 Million
Q4 2024

A detailed history of Riverview Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Riverview Trust CO holds 7,299 shares of ABBV stock, worth $1.41 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

7,299

Previous 7,344 0.61%

Holding current value

$1.41 Million

Previous $1.45 Million 10.55%

% of portfolio

1.21%

Previous 1.29%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$164.99 - $203.87 $7,424 - $9,174	-45 Reduced 0.61%	7,299 $1.3 Million
Q3 2024 Oct 17, 2024	BUY	$163.84 - $199.33 $4,915 - $5,979	30 Added 0.41%	7,344 $1.45 Million
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $55,724 - $65,073	-360 Reduced 4.69%	7,314 $1.25 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $5,366 - $6,043	39 Added 0.51%	7,674 $1.19 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $23,851 - $29,682	-180 Reduced 2.3%	7,635 $1.03 Million
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $25,310 - $30,354	-183 Reduced 2.29%	7,815 $1.26 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $25,365 - $29,092	-189 Reduced 2.31%	7,998 $1.07 Million
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $34,267 - $43,565	249 Added 3.14%	8,187 $1.25 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $103,736 - $128,707	786 Added 10.99%	7,938 $1.29 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $77,994 - $98,685	726 Added 11.3%	7,152 $968,000
Q3 2021 Oct 14, 2021	BUY	$106.4 - $120.78 $80,438 - $91,309	756 Added 13.33%	6,426 $693,000
Q2 2021 Jul 16, 2021	SELL	$105.21 - $117.21 $33,667 - $37,507	-320 Reduced 5.34%	5,670 $639,000
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $10,061 - $13,583	-125 Reduced 2.04%	5,990 $642,000
Q3 2020 Oct 15, 2020	SELL	$85.91 - $100.83 $3,865 - $4,537	-45 Reduced 0.73%	6,115 $536,000
Q2 2020 Jul 08, 2020	SELL	$73.37 - $98.18 $23,478 - $31,417	-320 Reduced 4.94%	6,160 $605,000
Q1 2020 Apr 15, 2020	SELL	$64.5 - $97.79 $238,650 - $361,823	-3,700 Reduced 36.35%	6,480 $494,000
Q4 2019 Jan 10, 2020	SELL	$72.13 - $90.25 $42,051 - $52,615	-583 Reduced 5.42%	10,180 $902,000
Q3 2019 Oct 16, 2019	SELL	$62.98 - $75.72 $312,506 - $375,722	-4,962 Reduced 31.55%	10,763 $815,000
Q2 2019 Jul 12, 2019	SELL	$65.7 - $83.98 $46,187 - $59,037	-703 Reduced 4.28%	15,725 $1.14 Million
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $2,777 - $3,268	36 Added 0.22%	16,428 $1.32 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $1.28 Million - $1.57 Million	16,392 New	16,392 $1.51 Million

Others Institutions Holding ABBV

# of Institutions

3,995

Shares Held

1.29B

Call Options Held

18.2M

Put Options Held

13.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.

Account

Riverview Trust CO Abb Vie Inc. Transaction History